Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Perlman

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
The International Journal on Drug Policy|December 4, 2014
Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugsDavid C Perlman, Ashly E Jordan
Current Infectious Disease Reports|June 1, 2001
Mycobacterial Infections of the Head and NeckDavid C. Perlman, Ron D'Amico, Nadim Salomon
The American Journal of Medicine|July 29, 2019
Scleritis and Endophthalmitis Due to Streptococcus pyogenes Infective EndocarditisHayato Mitaka, Tessa Gomez, David C Perlman
The Journal of Infection|January 13, 2006
Pneumonia and bacteremia due to Serratia odoriferaJungmin Lee, Jeanne Carey, David C Perlman
The International Journal on Drug Policy|October 8, 2024
Historical and theoretical roots of the big events frameworkSamuel R Friedman, Diana Rossi, David C Perlman
Frontiers in Public Health|January 26, 2017
Conceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention ContinuaDavid C Perlman, Ashly E Jordan, Denis Nash
Journal of Addictive Diseases|June 16, 2015
Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?David C Perlman, Don C Des Jarlais, Jonathan Feelemyer
Science & Practice Perspectives|June 24, 2008
HIV/hepatitis prevention in drug abuse treatment programs: guidance from researchJames L Sorensen, Carmen L Masson, David C Perlman
International Journal of STD & AIDS|November 13, 2013
Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected personsMasako Mizusawa, David C Perlman, David Lucido, et al.
American Journal of Orthopedics (Belle Mead, N.J.)|August 16, 2012
Septic arthritis and osteomyelitis due to the chromoblastomycosis agent Fonsecaea pedrosoiLeonidiz De Guzman, David C Perlman, Christopher E Hubbard
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
The International Journal on Drug Policy|December 4, 2014
Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugsDavid C Perlman, Ashly E Jordan
Current Infectious Disease Reports|June 1, 2001
Mycobacterial Infections of the Head and NeckDavid C. Perlman, Ron D'Amico, Nadim Salomon
The American Journal of Medicine|July 29, 2019
Scleritis and Endophthalmitis Due to Streptococcus pyogenes Infective EndocarditisHayato Mitaka, Tessa Gomez, David C Perlman
The Journal of Infection|January 13, 2006
Pneumonia and bacteremia due to Serratia odoriferaJungmin Lee, Jeanne Carey, David C Perlman
The International Journal on Drug Policy|October 8, 2024
Historical and theoretical roots of the big events frameworkSamuel R Friedman, Diana Rossi, David C Perlman
Frontiers in Public Health|January 26, 2017
Conceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention ContinuaDavid C Perlman, Ashly E Jordan, Denis Nash
Journal of Addictive Diseases|June 16, 2015
Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?David C Perlman, Don C Des Jarlais, Jonathan Feelemyer
Science & Practice Perspectives|June 24, 2008
HIV/hepatitis prevention in drug abuse treatment programs: guidance from researchJames L Sorensen, Carmen L Masson, David C Perlman
International Journal of STD & AIDS|November 13, 2013
Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected personsMasako Mizusawa, David C Perlman, David Lucido, et al.
American Journal of Orthopedics (Belle Mead, N.J.)|August 16, 2012
Septic arthritis and osteomyelitis due to the chromoblastomycosis agent Fonsecaea pedrosoiLeonidiz De Guzman, David C Perlman, Christopher E Hubbard
Pageof 12